A total of 344 properties were sold via auction last week. Realestate.com.au data division Proptrack has reported 1174 local auction and private sale results in the past seven days.

Adjusted additionally for expected currency impact, Philip Morris expects 2025 earnings of $7.26 a share to $7.39 a share. Philip Morris’s stock rose 9% to $143.09 in recent tra ...

Philip Morris (PM) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.36 per share a year ago. These figures ...

Revenue rose 7.3% year-over-year during the quarter to $9.71 billion. On an organic basis, revenue was also up 7.3%. Total ...

The market expects Philip Morris (PM) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at www.pmi.com/2024Q4earnings on Thursday, February 6, 2025, at 9:00 a.m. ET, to ...

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris International, which faced a yearslong decline in cigarette smoking.

At Holdings Channel, we have reviewed the latest batch of the 29 most recent 13F filings for the 12/31/2024 reporting period, and noticed that Philip Morris International Inc (Symbol: PM ...

"I do not support resuscitating dead projects such as the failed Northern Gateway pipeline, which would have been an absolute disaster for our lands and waters," Grand Chief Stewart Phillip said ...

Philip Haywood, Kentucky’s all-time winningest high school football coach, died Wednesday at University of Kentucky Hospital in Lexington. He was 73. Belfry athletics director Matt Varney ...

In this article, we are going to take a look at where Philip Morris International Inc. (NYSE:PM) stands against other best sin stocks to invest in 2025. Sin stocks are shares of companies involved ...

The life that Watson had with Sherlock is not done with him,” executive producer Craig Sweeny promises of the new CBS drama starring Morris Chestnut as the iconic doctor, John Watson.